Is Low-Dose Naltrexone Covered by Insurance? A 2026 Guide
Coverage depends on what form of naltrexone you mean. Low-dose naltrexone (LDN) is usually an off-label, often compounded prescription, while 50 mg oral naltrexone and monthly extended-release naltrexone are established addiction-treatment options with different insurance pathways.
Quick answer
LDN coverage is inconsistent. Many plans do not routinely reimburse compounded medications, and an insurer may require prior authorization or documentation of medical necessity. By contrast, standard-dose oral naltrexone and extended-release injectable naltrexone may be covered for alcohol or opioid use disorder depending on the plan.
If you are researching naltrexone for alcohol or opioid addiction, do not assume that information about “low-dose naltrexone” applies to addiction treatment. The dose, indication, evidence base and insurance process are different.
Low-dose naltrexone
Usually means doses well below the standard 50 mg tablet and is commonly prescribed off-label for non-addiction conditions. It is frequently prepared by a compounding pharmacy.
Oral naltrexone 50 mg
An FDA-approved prescription option used in treatment plans for alcohol dependence and for opioid blockade after an adequate opioid-free period.
Extended-release naltrexone
Vivitrol is an FDA-approved monthly injection for alcohol dependence and prevention of relapse to opioid dependence after detoxification. Coverage varies by insurer.
Why low-dose naltrexone can be harder to insure
LDN is not a separate FDA-approved drug product. In practice, clinicians may prescribe naltrexone at lower doses for off-label uses, and pharmacies may compound a specific strength. The FDA notes that compounded drugs are not FDA-approved and are not reviewed by the agency for safety, effectiveness or manufacturing quality before marketing. That difference matters to many benefit plans.
Insurance policies also differ in how they treat compounded prescriptions, out-of-network pharmacies and off-label use. For that reason, a blanket statement such as “LDN is covered” or “LDN is never covered” is unreliable. The useful question is whether your plan covers the exact prescription, pharmacy and diagnosis your clinician is using.
What to ask your insurer before paying cash
| Question | Why it matters | What to write down |
|---|---|---|
| Is this medication covered under pharmacy benefits? | Some plans treat compounded prescriptions differently from standard retail prescriptions. | Formulary tier, copay/coinsurance and deductible status. |
| Is prior authorization required? | Your prescriber may need to submit clinical information before coverage is considered. | Authorization number, required forms and deadline. |
| Does the plan cover compounded medication? | LDN may be dispensed at a compounding pharmacy. | Eligible pharmacies and any ingredient-level restrictions. |
| Is a letter of medical necessity accepted? | Some plans allow an exception or appeal process. | Appeal address, documentation requirements and review timeframe. |
| Would standard-dose naltrexone be covered for AUD/OUD? | If the goal is addiction treatment, this is often the more relevant insurance question. | Coverage for oral naltrexone and extended-release injection. |
If your real question is about addiction treatment
For alcohol use disorder and opioid use disorder, naltrexone is one of several evidence-based medication options. SAMHSA lists naltrexone among medications used for alcohol use disorder and, alongside buprenorphine and methadone, among medication options for opioid use disorder. Treatment choice should be individualized rather than based on price or duration alone.
For opioid use disorder in particular, naltrexone must not be started while a person is physically dependent on opioids. Current U.S. labeling warns about precipitated withdrawal and the need for an adequate opioid-free interval before treatment. This is one reason a medical assessment matters before comparing products.
Comparing naltrexone options for addiction recovery?
DeBinge provides an international long-acting naltrexone implant program in Nassau, The Bahamas. This is not the same product as low-dose naltrexone and it should not be presented as a substitute for every FDA-approved U.S. treatment option. Suitability depends on diagnosis, opioid-free status, medical history and the patient’s recovery plan.
DeBinge’s treatment route is self-pay and currently costs approximately $21,000–$23,000, depending on the planned stay and clinical needs, and includes ongoing recovery support. Insurance reimbursement is not guaranteed.
How to compare options without being misled
Compare like with like
Do not compare LDN cash pricing with a full treatment program, or a monthly injection with a residential program, without separating medication cost from clinical and aftercare costs.
Ask what is included
Medication, prescriber visits, laboratory testing, detoxification, counseling, accommodation and follow-up may be billed separately or bundled.
Check the evidence
Ask whether claims refer to the exact formulation being offered, the population studied and the outcome measured.
Insurance coverage checklist
Use these questions when speaking to your insurer or pharmacy benefits manager. Ask for written confirmation and record the call reference number.
Frequently asked questions
Is LDN the same as naltrexone used for addiction?
No. The active ingredient is the same, but “LDN” usually refers to much lower off-label doses, often for non-addiction conditions. Addiction treatment commonly uses standard-dose oral naltrexone or extended-release naltrexone under medical supervision.
Will Medicare or private insurance pay for LDN?
Possibly, but there is no universal answer. Coverage depends on the plan, diagnosis, pharmacy and whether a compounded prescription is eligible. Call the plan using the exact prescription information from the prescriber.
Does insurance cover Vivitrol?
Many insured patients have coverage, but benefits and out-of-pocket costs vary. The manufacturer currently provides a benefits-verification service and financial-support information for eligible patients.
Can I start naltrexone immediately after using opioids?
Not safely in every case. U.S. prescribing information warns that naltrexone can precipitate severe withdrawal if started before an adequate opioid-free period. Medical assessment is essential.
Review status: Pending.
Clinical reviewer: Dr Fergus Law, BSc, MBChB, FRCPsych, Consultant Psychiatrist specialising in substance misuse and addiction.
- U.S. FDA — Consumer and Health Care Professional Information on Compounded Drugs
- DailyMed — Naltrexone Hydrochloride prescribing information
- SAMHSA — Treatment Options for Substance Use Disorder
- Vivitrol — Insurance benefits verification and support
- DeBinge Research & Resources Library
This page is educational and does not replace medical advice or an insurer’s written benefit determination. Coverage and prices can change.